Ira Wollner

Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates

Julie R. Brahmer, Charles G. Drake, Ira Wollner et al. · Journal of Clinical Oncology · 2010 · 2.9K citations · Full text

Medicine, Oncology, Pharmacology +17

Durable Cancer Regression Off-Treatment and Effective Reinduction Therapy with an Anti-PD-1 Antibody

Evan J. Lipson, William H. Sharfman, Charles G. Drake et al. · Clinical Cancer Research · 2012 · 543 citations

Medicine, Immunology, Oncology +17

Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates

Julie R. Brahmer, Charles G. Drake, Ira Wollner et al. · Journal of Clinical Oncology · 2023 · 220 citations

Medicine, Oncology, Pharmacology +17

Effects of hepatic arterial yttrium 90 glass microspheres in dogs

Ira Wollner, Conrad Knutsen, Patricia Smith et al. · Cancer · 1988 · 101 citations · Full text

Medicine, Nuclear Medicine, Radiology +16

Steady-state nonlinear pharmacokinetics of 5-fluorouracil during hepatic arterial and intravenous infusions in cancer patients.

John G. Wagner, John W. Gyves, Philip L. Stetson et al. · PubMed · 1986 · 92 citations

Pharmacy, Pharmacokinetics, Pharmacology +17